Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Moderna Inc biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines and Recipharm STO RECIB a leading contract development and manufacturing organization CDMO
Centene Corporation today announced that it has completed its acquisition of PANTHERx one of the largest and fastestgrowing specialty pharmacies in the United States specializing in orphan drugs and treating rare diseases
Hutchison China MediTech Limited ChiMed today announces that surufatinib has been granted approval for drug registration by the National Medical Products Administration of China NMPA for the treatment of nonpancreatic neuroendocrine tumors NETs Suruf...
Altimmune Inc a clinicalstage biopharmaceutical company today announced that it has enrolled the first patient in its multinational Phase clinical trial of HepTcell a novel peptidebased immunotherapeutic under development for treatment of chronic he...
Arcturus Therapeutics Holdings Inc a leading clinicalstage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases
Propanc Biopharma Inc a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer announced today that the Proenzymes Optimization Project POP joint research and drug discovery program a...
Glenmark Pharmaceuticals Limited Glenmark a researchled global pharmaceutical company has launched a fixed dose combination FDC of its novel patent protected and globally researched Sodium Glucose CoTransporter Inhibitor SGLTi
Amphastar Pharmaceuticals Inc announced that the US Food and Drug Administration FDA has approved its Abbreviated New Drug Application ANDA for Glucagon for Injection Emergency Kit mg Glucagon is indicated for the treatment of severe hypoglycemia an...
Clovis Oncology Inc today announced that the company has completed submission of two Investigational New Drug IND applications to the US Food and Drug Administration FDA for FAP the lead compound in its peptidetargeted radionuclide therapy PTRT devel...
Eyenovia Inc a clinical stage ophthalmic biopharmaceutical company with Phase programs in presbyopia myopia and mydriasis today announced that it has submitted a New Drug Application NDA to the U S Food and Drug Administration FDA for MydCombi a uni...
